ClariTrial | Search Clinical Trials

Explore/HIV Infections

Status

Phase

12,080 results for “HIV Infections”

Page 1 of 806

Completed

Results posted

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Phase 2Anal Neoplasm

VGX-3100CELLECTRA™ 5PSP

Inovio Pharmaceuticals23 participants3 sites · United States, CanadaCompletes Jun 2020

Compare CT.gov Full analysis →

Completed

Results posted

Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children

Phase 2Phase 3Acquired Immune Deficiency Syndrome (AIDS)HIV Infections

E/C/F/TAFE/C/F/TAF (Low Dose)

Gilead Sciences129 participants16 sites · United States, South Africa, ThailandCompletes May 2020

Compare CT.gov Full analysis →

UNKNOWN

PrEPared-RN, CAN Nurse-Led Management of High-risk Patients for Pre-Exposure Prophylaxis (PrEP)

N/AHiv PreventionPre-Exposure Prophylaxis (PrEP)

Truvada

CAN Community Health210 participants5 sites · United StatesCompletes Jul 2025

Compare CT.gov Full analysis →

Recruiting

Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

Phase 1HIV Infections

VH4524184[14C]VH4524184 microdose[14C]VH4524184

ViiV Healthcare9 participants1 site · NetherlandsCompletes Aug 2026

Compare CT.gov Full analysis →

Completed

A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis

Phase 2Tuberculous Meningitis

81mg aspirin1000mg aspirinPlacebo

Oxford University Clinical Research Unit, Vietnam120 participants1 site · VietnamCompletes Jun 2016

Compare CT.gov Full analysis →

Completed

A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth

Phase 1HIV Infections

Zidovudine

National Institute of Allergy and Infectious Diseases (NIAID)18 participants6 sites · United States

Compare CT.gov Full analysis →

Completed

Results posted

Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients

N/ATuberculosisNon-tuberculous Mycobacterial Diseases (Including MAC Disease)

rifabutin

Pfizer628 participantsCompletes Jul 2016

Compare CT.gov Full analysis →

Completed

Results posted

Texting to Improve Adherence in HIV+ With Bipolar Disorder

N/AHIV DiseaseBipolar Disorder

Psychoeducationindividualized Texting for Adherence Building (iTAB)

University of California, San Diego58 participants1 site · United StatesCompletes Mar 2012

Compare CT.gov Full analysis →

Completed

Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected Men

N/AHIV Infections

Cognitive behavioral interventionStandard counseling

University of California, San Francisco488 participants2 sites · United StatesCompletes Dec 2010

Compare CT.gov Full analysis →

Recruiting

Platelets Target the Circulating HIV Reservoir: Implications for Immunological Failure

N/AHIV

blood sampling

Tourcoing Hospital90 participants1 site · FranceCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB

Phase 4MDR-TBImmunotherapy

Vγ2Vδ2 T lymphocyte-based immunotherapyTreatment regimens for MDR-TB

Shanghai Pulmonary Hospital, Shanghai, China30 participants2 sites · ChinaCompletes Aug 2025

Compare CT.gov Full analysis →

Completed

Results posted

Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa

N/ATuberculosis

Active TB case finding

Johns Hopkins Bloomberg School of Public Health4,852 participants2 sites · South AfricaCompletes Jan 2018

Compare CT.gov Full analysis →

Terminated

Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected Adults

Phase 1Healthy VolunteerHIV Vaccine

Ad4-mgagAd4-EnvC150Placebo Comparator+1 more

Emergent BioSolutions20 participants1 site · United StatesCompletes Feb 2017

Compare CT.gov Full analysis →

Completed

A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects

Phase 1HIV Infections

HIV-1 Peptide Vaccine, Microparticulate Monovalentrgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine

United Biomedical1 site · United States

Compare CT.gov Full analysis →

Terminated

Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection

Phase 1HIV-1 Infection

VorinostatAGS-004

University of North Carolina, Chapel Hill6 participants1 site · United StatesCompletes Jul 2018

Compare CT.gov Full analysis →

1–15 of 12,080

Explore/HIV Infections

Status

Phase

12,080 results for “HIV Infections”

Page 1 of 806

Completed

Results posted

Phase 2Anal Neoplasm

VGX-3100CELLECTRA™ 5PSP

Inovio Pharmaceuticals23 participants3 sites · United States, CanadaCompletes Jun 2020

Compare CT.gov Full analysis →

Completed

Results posted

Phase 2Phase 3Acquired Immune Deficiency Syndrome (AIDS)HIV Infections

E/C/F/TAFE/C/F/TAF (Low Dose)

Gilead Sciences129 participants16 sites · United States, South Africa, ThailandCompletes May 2020

Compare CT.gov Full analysis →

UNKNOWN

PrEPared-RN, CAN Nurse-Led Management of High-risk Patients for Pre-Exposure Prophylaxis (PrEP)

N/AHiv PreventionPre-Exposure Prophylaxis (PrEP)

Truvada

CAN Community Health210 participants5 sites · United StatesCompletes Jul 2025

Compare CT.gov Full analysis →

Recruiting

Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

Phase 1HIV Infections

VH4524184[14C]VH4524184 microdose[14C]VH4524184

ViiV Healthcare9 participants1 site · NetherlandsCompletes Aug 2026

Compare CT.gov Full analysis →

Completed

A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis

Phase 2Tuberculous Meningitis

81mg aspirin1000mg aspirinPlacebo

Oxford University Clinical Research Unit, Vietnam120 participants1 site · VietnamCompletes Jun 2016

Compare CT.gov Full analysis →

Completed

A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth

Phase 1HIV Infections

Zidovudine

National Institute of Allergy and Infectious Diseases (NIAID)18 participants6 sites · United States

Compare CT.gov Full analysis →

Completed

Results posted

Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients

N/ATuberculosisNon-tuberculous Mycobacterial Diseases (Including MAC Disease)

rifabutin

Pfizer628 participantsCompletes Jul 2016

Compare CT.gov Full analysis →

Completed

Results posted

Texting to Improve Adherence in HIV+ With Bipolar Disorder

N/AHIV DiseaseBipolar Disorder

Psychoeducationindividualized Texting for Adherence Building (iTAB)

University of California, San Diego58 participants1 site · United StatesCompletes Mar 2012

Compare CT.gov Full analysis →

Completed

Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected Men

N/AHIV Infections

Cognitive behavioral interventionStandard counseling

University of California, San Francisco488 participants2 sites · United StatesCompletes Dec 2010

Compare CT.gov Full analysis →

Recruiting

Platelets Target the Circulating HIV Reservoir: Implications for Immunological Failure

N/AHIV

blood sampling

Tourcoing Hospital90 participants1 site · FranceCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB

Phase 4MDR-TBImmunotherapy

Vγ2Vδ2 T lymphocyte-based immunotherapyTreatment regimens for MDR-TB

Shanghai Pulmonary Hospital, Shanghai, China30 participants2 sites · ChinaCompletes Aug 2025

Compare CT.gov Full analysis →

Completed

Results posted

Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa

N/ATuberculosis

Active TB case finding

Johns Hopkins Bloomberg School of Public Health4,852 participants2 sites · South AfricaCompletes Jan 2018

Compare CT.gov Full analysis →

Terminated

Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected Adults

Phase 1Healthy VolunteerHIV Vaccine

Ad4-mgagAd4-EnvC150Placebo Comparator+1 more

Emergent BioSolutions20 participants1 site · United StatesCompletes Feb 2017

Compare CT.gov Full analysis →

Completed

A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects

Phase 1HIV Infections

HIV-1 Peptide Vaccine, Microparticulate Monovalentrgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine

United Biomedical1 site · United States

Compare CT.gov Full analysis →

Terminated

Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection

Phase 1HIV-1 Infection

VorinostatAGS-004

University of North Carolina, Chapel Hill6 participants1 site · United StatesCompletes Jul 2018

Compare CT.gov Full analysis →

1–15 of 12,080